A comprehensive view of Obesity. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global soft tissue repair market expected to grow to US$17.2B by 2027, with CAGR growth of 4.7% from 2022 to 2027; growth driven by increases in obesity, cardiovascular diseases, trauma, growing need to manage patient blood loss, increasing R&D in field
Published: June 27, 2022 by PR Newswire
FDA approves Rhythm Pharmaceuticals’ Imcivree setmelanotide injectable to treat obesity in patients with Bardet-Biedl syndrome; FDA did not approve drug for patients with Alstroem syndrome
Published: June 23, 2022 by SeeNews Pharmaceuticals
Allurion Technologies launches clinical trial NCT05368259 to study effectiveness, safety of Allurion Gastric Balloon System and moderate intensity lifestyle to promote weight loss; AGBS involves placement of up to two balloons in one-year period
Published: May 26, 2022 by Cancer Vaccine Daily
FDA approves Eli Lilly’s injectable Mounjaro tirzepatide type 2 diabetes drug that lowers blood sugar, helps patients lose weight; Mounjaro sales projected to reach up to US$14B annually by 2030
Published: May 17, 2022 by STAT News
FDA approves Ilya Pharma’s IND for ILP100-Topical immunotherapy surgical wound treatment for patients with prediabetes, diabetes, obesity; company accelerating plans for Phase 2 study, with patients in study having increased risk of wound complications
Published: May 06, 2022 by Canada Newswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count